MILTENYI BIOTEC BV & CO KG

Forschungsprojekte

• FINE-TUNING T CELL NETWORKS OF EXHAUSTION BY SYNTHETIC SENSORS Cell and gene therapies offer a massive paradigm shift from current treatment options and hold the potential…
• Training the next-generation of European GLIOblastoma (translational) researchers, to RESOLVE precision targeting of the brain tumour microenvironment Isocitrate dehydrogenase wildtype (IDHwt) glioblastoma (GBM) is the most frequent, aggressive and lethal brai…
• Gene Therapy of Rare Diseases More than 300 million people worldwide are suffering from more than 6000 rare diseases. Nearly all of these r…
• Future of ALCL: Novel Therapies, Origins, Bio-Markers and Mechanism of resistance The FANTOM Doctoral Network (DN) composed of 7 beneficiaries and 12 associated partners in 5 EU countries, re…
• Carreras Postdoc Program Empowering Future Leaders to Fight Blood Cancers CarrerasLeaders is a new innovative and international postdoctoral programme, designed by Josep Carreras Leuk…
• Autoantigen-specific adoptive regulatory T cell therapy against type 1 diabetes (ARTiDe) Type 1 diabetes (T1D) is an incurable disease, often starting in childhood, with a risk of devastating compli…